0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessAlthough increasing studies have reported that dose escalation can improve treatment response to ustekinumab in patients with Crohn's disease (CD), their strategies mainly focus on maintenance regimen. Evidence of ustekinumab dose escalation in induction regimen, particularly in severe CD, remains limited. This study evaluated the efficacy and safety of intravenous ustekinumab with 2 initial doses in patients with severely active CD.
Haixia Ren, Jian Jian Kang, Jing Wang, Juan Su, Li‐Ping Zou, Anning Yin, Jiao Li, Qian Zhou, Wei Wang, Zhishun Tang, Jing Zhang, Yueyue Lu, Yuanping Yang, Chengen Qiu, Yijuan Ding, Weiguo Dong, Ping An (2023). Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn’s Disease. , 30(8), DOI: https://doi.org/10.1093/ibd/izad184.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2023
Authors
17
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1093/ibd/izad184
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
